Beta Testing Awards Program - Care Hub

Beta Testing Awards Program

Building Community, Earning Rewards, Creating Impact

Total Participants

50

Strategic capacity limit across all participant types

Token Rewards

2.6M

Total CCC tokens allocated for beta program

Avg. Earning Potential

~$458

Per participant (~52,000 CCC at $0.0088 ICO price)

Join Beta Testing

Use Code: BETA25WEB
I. Executive Summary

The Care Hub Beta Testing Awards Program is a capacity-controlled initiative designed to rigorously test our platform with diverse community participants while providing meaningful token-based compensation for valuable feedback and engagement.

Program Highlights

  • 50 Total Participants: Strategic capacity limits ensure sustainable operations and quality engagement
  • 11 Participant Types: From cancer patients to digital marketing professionals
  • CareCoin Rewards: Earn 2,900-5,800 CCC (~$26-$51) per module completion, 1,100-5,800 CCC (~$10-$51) per bug report
  • 2.6M Total Tokens: Controlled allocation protects token economics
  • ICO Conversion: Tokens convert to transferable blockchain assets at $0.0088 initial valuation
  • 68% High Priority: Allocation weighted toward patients, caregivers, and clinical professionals

Why Capacity Limits?

Unlike unlimited enrollment, our 50-participant cap enables:

  • Cost Management: Predictable token distribution and sustainable economics
  • Quality Engagement: Meaningful relationships with each participant
  • Strategic Prioritization: Focus on participant types most critical to platform success
  • High-Touch Support: Personalized onboarding and ongoing assistance

Participant Allocation Strategy

68% High Priority: Cancer patients (30%), survivors (10%), caregivers (20%), oncologists (4%), mental health practitioners (4%)

10% Medium Priority: Healthcare professionals (4%), nurses (6%)

22% Standard Priority: Researchers (6%), technology professionals (6%), patient advocates (6%), digital marketing (4%)

II. Participant Capacity Limits

Participant Capacity Limits

⚠️ Important: Strict Capacity Management

To ensure sustainable program operations and maintain high-quality engagement, we have implemented strict participant capacity limits based on participant type rather than access code or campaign.

Maximum Total Participants: 50

This capacity-based approach enables us to:

  • Control operational costs and token distribution
  • Maintain meaningful engagement with each participant
  • Prioritize participant types most critical to platform development
  • Ensure quality feedback from diverse community perspectives

Allocation Strategy

Our allocation is strategically weighted toward cancer patients, caregivers, and clinical professionals who represent the core user base and can provide the most valuable insights for platform development.

Participant Type Allocation Priority Percentage
Cancer Patients 15 spots HIGH 30%
Cancer Survivors 5 spots HIGH 10%
Family/Caregivers 10 spots HIGH 20%
Oncologists 2 spots HIGH 4%
Mental Health Practitioners 2 spots HIGH 4%
Healthcare Professionals 2 spots MEDIUM 4%
Nurses/Healthcare Workers 3 spots MEDIUM 6%
Researchers 3 spots STANDARD 6%
Technology Professionals 3 spots STANDARD 6%
Patient Advocates 3 spots STANDARD 6%
Digital Marketing Professionals 2 spots STANDARD 4%

Total: 50 participants | HIGH Priority: 68% | MEDIUM Priority: 10% | STANDARD Priority: 22%

III. Participant Type Objectives

Participant Type Objectives

HIGH PRIORITY PARTICIPANTS (68% of allocation)

Cancer Patients (15 spots - 30%)

Primary Objectives:

  • Test patient-facing features including profile forms, symptom tracking, and wellness monitoring
  • Evaluate emotional support tools and mental health resources
  • Provide feedback on information architecture and content relevance across different cancer types
  • Assess usability during active treatment when cognitive load and fatigue are factors
  • Identify unmet needs and critical gaps in current cancer care support systems

Why Critical: Active patients represent our primary user base and face immediate daily challenges the platform aims to address. Their real-time experiences during treatment provide invaluable insights that cannot be replicated.


Cancer Survivors (5 spots - 10%)

Primary Objectives:

  • Test survivorship-specific features including long-term monitoring and follow-up care coordination
  • Evaluate post-treatment quality of life tracking and late effects management
  • Provide perspective on transition from active treatment to survivorship
  • Test peer mentorship and community connection features
  • Assess resources for managing fear of recurrence and psychological recovery
  • Evaluate support resources designed specifically for survivor needs and challenges
  • Test peer-to-peer support features connecting survivors with newly diagnosed patients

Why Critical: Survivors offer retrospective insights on the complete cancer journey and can identify features that would have been helpful during their treatment, plus they understand ongoing survivorship challenges.


Family Members/Caregivers (10 spots - 20%)

Primary Objectives:

  • Test caregiver-specific profile forms and assessment tools
  • Evaluate caregiver burden tracking and self-care resources
  • Identify unique caregiver needs often overlooked by healthcare systems
  • Test coordination tools for managing patient appointments, medications, and care teams
  • Assess emotional support resources for caregiver stress, anxiety, and compassion fatigue
  • Evaluate dedicated caregiver support features and community connection tools
  • Test respite care resources and caregiver wellness tracking capabilities

Why Critical: Caregivers are the invisible backbone of cancer care, yet their needs are consistently underserved. This allocation recognizes that caregiver wellbeing directly impacts patient outcomes and represents a critical platform differentiator.


Oncologists (2 spots - 4%)

Primary Objectives:

  • Validate medical accuracy of cancer information and educational content
  • Evaluate clinical utility of patient-reported outcome tracking features
  • Assess potential integration with clinical workflows and EHR systems
  • Identify features that could improve patient-oncologist communication
  • Provide expert feedback on treatment information presentation and resource recommendations

Why Critical: Oncologist validation ensures clinical credibility, helps identify features that could enhance (not disrupt) clinical practice, and provides expert perspective on medical content accuracy essential for platform trustworthiness.


Mental Health Practitioners (2 spots - 4%)

Primary Objectives:

  • Evaluate psychological support resources and mental health tools
  • Assess emotional wellbeing tracking and coping mechanism features
  • Test crisis intervention resources and support system integration
  • Validate mental health content for accuracy and clinical appropriateness
  • Identify gaps in psychosocial support for patients, caregivers, and survivors

Why Critical: Mental health is a critical yet often overlooked aspect of cancer care. Practitioners specializing in oncology psychology, counseling, or therapy provide essential expertise in evaluating the platform's emotional support infrastructure.


MEDIUM PRIORITY PARTICIPANTS (10% of allocation)

Healthcare Professionals (2 spots - 4%)

Primary Objectives:

  • Test interdisciplinary care coordination features (PCPs, specialists, allied health)
  • Evaluate holistic care resources including nutrition, physical therapy, social work
  • Assess general healthcare provider usability and workflow integration
  • Provide non-oncology perspective on comprehensive cancer care support

Nurses/Healthcare Workers (3 spots - 6%)

Primary Objectives:

  • Test practical day-to-day patient support features and educational resources
  • Evaluate symptom management tools and patient education materials
  • Provide frontline clinical perspective on patient needs and common questions
  • Assess accessibility of medical information for diverse health literacy levels

STANDARD PRIORITY PARTICIPANTS (22% of allocation)

Researchers (3 spots - 6%)

Primary Objectives:

  • Evaluate research information presentation and NIH PDQ integration
  • Test clinical trial matching and research participation features
  • Assess data collection methods for future research integration
  • Provide academic perspective on evidence-based content and resources

Technology Professionals (3 spots - 6%)

Primary Objectives:

  • Conduct technical stress testing and identify bugs, security vulnerabilities
  • Evaluate user experience, interface design, and navigation architecture
  • Test cross-browser compatibility and responsive design
  • Assess performance, load times, and technical optimization opportunities

Patient Advocates (3 spots - 6%)

Primary Objectives:

  • Evaluate patient empowerment tools and advocacy resources
  • Test community connection and peer support features
  • Assess accessibility for diverse patient populations and cultural sensitivity
  • Provide perspective on patient rights, healthcare navigation, and system barriers

Digital Marketing Professionals (2 spots - 4%)

Primary Objectives:

  • Evaluate user onboarding flow and engagement optimization
  • Test content presentation and communication strategies
  • Assess brand messaging, positioning, and community growth potential
  • Provide feedback on user acquisition and retention strategies
IV. Token Rewards Structure

Token Rewards Structure

CareCoin (CCC) Rewards

Beta participants earn CareCoin tokens through active engagement and feedback completion. Tokens are initially recorded on a secure loyalty ledger and will convert to transferable blockchain tokens at the Initial Coin Offering (ICO).

Earning Opportunities

Activity Token Reward (CCC) USD Equivalent Description
Module Completion 2,900-5,800 ~$26-$51 Complete educational modules with feedback surveys
Profile Form Completion 2,900 ~$26 Complete patient or caregiver profile assessments
Feature Testing 2,900 ~$26 Test specific features and provide detailed feedback
Bug Reporting 1,100-5,800 ~$10-$51 Identify and document bugs (severity-based rewards)
Weekly Check-In 1,700 ~$15 Complete weekly engagement survey
Community Feedback 2,300 ~$20 Participate in community discussions and provide insights
Referral Bonus 11,500 ~$101 Refer eligible participant who completes onboarding

Estimated Token Potential

Active participants engaging with all available modules and features can earn:

  • Initial 5 Modules: 14,500 CCC (~$128 USD)
  • Weekly Check-Ins (8 weeks): 13,600 CCC (~$120 USD)
  • Additional Feature Testing: 11,500-23,000 CCC (~$101-$202 USD)
  • Bug Reports & Feedback: 5,800-17,400 CCC (~$51-$153 USD)
  • Total Estimated Range: 45,400-68,500 CCC (~$400-$603 USD per active participant)

Cost Management Strategy:

With 50 participants earning an average of 52,000 CCC each, total beta program distribution = 2.6 million CCC tokens

At $0.0088 ICO price, this represents approximately $22,880 in total value (~$458 per participant). This controlled allocation ensures sustainable token economics while providing meaningful rewards for valuable community contributions.

Token Value & Conversion

Understanding Your Token Value:

Your participation is tracked on a secure loyalty ledger using your CCH ID. This loyalty ledger balance will be converted into transferable CareCoin tokens at the time of the Initial Coin Offering (ICO).

Token-to-USD Equivalent: Each token has an initial ICO value equivalent to $0.0088 USD and will be converted into Solana-based tokens at ICO launch.

Example Calculations:

  • Complete 5 modules = 14,500 CCC = ~$128 USD equivalent
  • Complete 12 modules = 34,800 CCC = ~$306 USD equivalent
  • Complete 15 modules + weekly check-ins = 57,100 CCC = ~$502 USD equivalent
V. Important Disclaimers

Important Disclaimers

⚠️ Cryptocurrency & Financial Risk Acknowledgment

Project Transparency & Realistic Expectations:

This is an early-stage startup. Like any grassroots initiative, our future depends on community support, technical success, and sustainable funding. While we are deeply committed and have invested significant resources, we cannot guarantee the platform will operate indefinitely. The better the app we build together, the more viable this becomes for all of us. Your time investment isn't just about testing—it's about co-creating something the cancer community genuinely needs.

No Restrictions on Selling: Once tokens are converted to transferable cryptocurrency at ICO launch, you will have complete freedom to hold, trade, or sell your tokens without restrictions. There are no lock-up periods or limitations on when you can convert tokens to other currencies.

Financial Risk Acknowledgment: As this compensation involves cryptocurrency allocated at an upcoming ICO (marketing rollout targeted for Q4 2025), you acknowledge the inherent risks associated with cryptocurrency assets, including:

  • Price volatility and market fluctuations
  • Regulatory changes affecting cryptocurrency markets
  • Liquidity risks and exchange availability
  • Technology risks including smart contract vulnerabilities
  • Market adoption and competition from other projects

No Guarantee of Value: While each token has an initial ICO valuation of $0.0088 USD, the actual market value may vary significantly. The cryptocurrency market is highly volatile and unpredictable. Participation should not be viewed as financial investment advice or a guaranteed return.

Non-Monetary Until Conversion: Tokens remain as loyalty ledger credits with no monetary value until officially converted to transferable blockchain tokens at ICO launch. The timing of ICO launch is subject to development milestones, regulatory compliance, and market conditions.

Voluntary Participation: Participation in the token rewards program is entirely voluntary. You are contributing to beta testing and platform development first and foremost. Token rewards are a supplementary benefit, not the primary purpose of participation.

VI. Participant Requirements

Participant Requirements

Eligibility Requirements

  • Must be at least 18 years of age
  • Valid email address for program communications
  • Access to desktop/laptop computer (Phase 1 & 2 requirement)
  • Relevant experience in designated participant category
  • Completion of informed consent form
  • Commitment to 2 hours per week during active testing (October-November 2025)

Participation Expectations

  • Active Engagement: Regular platform usage and feature exploration
  • Feedback Completion: Thoughtful responses to surveys and feedback forms
  • Bug Documentation: Detailed reporting of issues, errors, and unexpected behaviors
  • Constructive Communication: Professional, respectful engagement with development team
  • Confidentiality: Respect for beta program privacy and non-disclosure requirements
VII. Registration & Selection Process

Registration & Selection Process

How to Apply

Step 1: Invite Code Acquisition

Use invite code BETA25WEB when registering through this page. This code is specifically designated for website inquiries and beta testing program enrollment.

Step 2: Account Registration

Create your Care Hub account by clicking on the Beta Testing button at cancer.davidlennard.com

Step 3: Participant Type Selection

During registration, indicate your participant type category. You may select multiple categories if applicable (e.g., Cancer Patient + Caregiver).

Step 4: Informed Consent

Complete the comprehensive informed consent form outlining program details, data usage, and participant rights.

Step 5: Profile Completion

Complete your participant profile to help us understand your unique perspective and testing focus areas.

⚠️ Capacity Monitoring

When a participant type category reaches capacity, registration for that category will automatically close. Interested individuals will be added to a waitlist and notified if spots become available.

Current Status: All participant types currently accepting registrations (as of October 19, 2025)

VIII. Data Privacy & Security

Data Privacy & Security

Beta testing participants receive the same enterprise-grade data protection as production users:

  • Invite-Only Access Control: Multi-layer verification system
  • Encrypted Data Transmission: HTTPS/SSL encryption for all communications
  • Anonymous Analytics: CCH ID system enables feedback without personal identification
  • Minimal Data Collection: Only essential information required for program participation
  • Daily Automated Backups: Multi-platform redundancy protects your data
  • GDPR & CCPA Compliant: Full user rights to access, correct, and delete data

Comprehensive Security Documentation

Full details available at: davidlennard.com/hipaa

IX. Beta Testing Timeline

Beta Testing Timeline

Phase 1: Web Application Testing (October-November 2025)

  • Focus: Desktop/laptop browser-based testing
  • Activities: Module testing, profile forms, tracking features, feedback surveys
  • Requirements: 2 hours per week active participation

Phase 2: Feature Expansion (November 2025)

  • Focus: Additional features based on Phase 1 feedback
  • Activities: Enhanced community features, advanced tracking, integration testing
  • Requirements: Continued engagement and iterative feedback

Phase 3: Mobile Optimization (November 2025)

  • Focus: Responsive design and mobile browser testing
  • Activities: Cross-device compatibility, mobile-specific features
  • Requirements: Testing across multiple devices and screen sizes

Phase 4: App Store Deployment (December 2025)

  • Focus: Native app testing and app store rollout
  • Activities: Download and installation testing, app-specific features
  • Requirements: iOS and/or Android device access

Phase 5: Full Public Release (Q1 2026)

  • Focus: Launch to wider cancer community
  • Beta Participant Role: Community ambassadors and ongoing advisors
X. Frequently Asked Questions

Frequently Asked Questions

Can I participate in multiple categories?

Yes! Many participants have multiple relevant experiences (e.g., cancer survivor who is also a caregiver, oncologist who is also a researcher). You will only occupy one allocation spot, but you can provide feedback from multiple perspectives.

What happens if my category reaches capacity?

You'll be added to a priority waitlist for that category. If a spot becomes available due to participant withdrawal, waitlist members will be contacted in order. You may also qualify for alternative categories if you have multiple relevant experiences.

How are tokens converted to real cryptocurrency?

Currently, CareCoin tokens are tracked on a secure loyalty ledger. At the Initial Coin Offering (ICO), your tokens will convert to transferable blockchain tokens that can be held, traded, or used within the Care Hub ecosystem. Timing and conversion details will be communicated as the ICO approaches.

Can I withdraw from the beta program?

Absolutely. Participation is entirely voluntary. You may withdraw at any time without penalty. Any tokens earned prior to withdrawal will remain in your account for future conversion. Contact research.carehub@gmail.com to initiate withdrawal.

What if I find a security vulnerability?

We actively encourage security testing and offer enhanced token rewards for responsible disclosure of security issues. Contact our security team immediately at research.carehub@gmail.com with details. Do not publicly disclose vulnerabilities.

Will my personal information be shared?

Never. All published results and social media communications use aggregated, anonymous data only. Your personally identifiable information is protected with enterprise-grade security and will never be shared, sold, or publicly disclosed.

XI. Community Transparency Commitment

Community Transparency Commitment

Open & Honest Development

We are committed to operating with complete transparency:

  • All beta testing rewards, token distributions, and compensation details will be posted publicly on our website and shared via social media
  • Community participants will have direct input in all major decision-making processes—from feature prioritization to design choices to platform governance
  • Regular updates on participant enrollment, capacity status, and program progress
  • Your voice matters, and we believe the best way to build a community-driven platform is to actively involve the community at every step
  • Building this together, openly and honestly
XII. Contact & Support

Contact & Support

Program Coordinator: David Lennard

Email: research.carehub@gmail.com

Ready to Join?

Register for Beta Testing Program

Use Invite Code: BETA25WEB

Limited spots available based on participant type capacity.

↑ Back to Top